














Jung Min Byun 
 
 
A thesis submitted to Johns Hopkins University in conformity with the requirements for 












The main cause of cancer related deaths is results from metastasis of cancer, or 
the spread of cancer to secondary sites. In order to metastasize, cancer cell migration is 
necessary. Numerous studies in cancer biology have examined mechanisms of cancer cell 
migration possible target molecules to prevent metastasis of cancer cells. During the early 
stages of metastasis, cancer cells penetrate through the basement membrane and invade 
into the extracellular matrix (ECM). During cell migration, integrins which are 
transmembrane receptors bind to extracellular matrix (ECM) molecules which mediate 
cell attachment and the formation of focal adhesions. Among many integrins, integrin 
α5β1 is often overexpressed in many cancer cells.  
We utilized 2D and 3D assays with an APRW model analysis to investigate the 
effect of downregulation of integrin α5 on cell motility using the metastatic breast cancer 
cell line, MDA-MB-231. We decreased integrin α5 expression using shRNA. Cells were 
plated on top of fibronectin, fibrinogen and collagen 2D substrates. Then, they were also 
embedded in a 3D collagen matrix and 3D collagen matrices with fibronectin. 2D and 3D 
cell movements were analyzed using an APRW model, saying cell movements are highly 
anisotropic. Furthermore, we performed focal adhesion staining on 2D cells to test 
correlation with cell migration 
Comparing 2D and 3D cell motility, we were able to observe integrin α5 had a 
remarkable effect on cell motility for 3D but showed less of an effect for 2D. We tested 
the correlation between 2D motility and focal adhesion and concluded that focal adhesion 
is not a predictor for 2D migration. With an increasing amount of fibronectin in 3D 
collagen matrices, the cell migration has decreased possibly due to the gel structure 
alteration. By investigating different parameters for cell motilities, such as diffusivity and 
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persistence time, we were able to test effect of downregulation of integrin α5 on cell 
motility in 3D. Finally, the APRW model provided better characterization of cell 
movement than measuring cell velocities from cell trajectories data. Downregulation of 
integrin α5 does not alter cell speed but decreases diffusivity and persistence of 
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 Metastasis is responsible for most cancer deaths. Primary tumors are often 
successfully removed by surgery or treated by irradiation. However, once tumor cells 
disseminate to other organs, it is very difficult to treat and ultimately leads to death. 
Moreover, for many patients, metastasis will occur years or even decades after initial 
diagnosis and primary treatment (Chambers et al., 2002). Multimodal therapy, 
combination of systemic therapy, surgery and radiotherapy, is used to treat cancers. 
Initial treatment of cancer often includes using chemotherapy and/or targeted agents 
interfering with selected signaling pathways (Tryfonidis et al., 2015).  
 Metastasis involves migration and proliferation processes (Gupta et al., 2010). 
Initially, cancer cell proliferation is essential at primary tumor sites. Then, cancer cells 
gain the ability to degrade, remodel and migrate through the extracellular matrix 
following penetration through the basement membrane. Once cells invade through the 
basement membrane and extracellular matrix, cancer cells enter the bloodstream and 
travel to distant sites via the vascular and lymphatic systems. Then, they colonize at 





Figure 1: Stages of metastasis. (A) Cancer cells grow at primary site with altered 
adhesion capacity onto surrounding cells and their microenvironment. (B) Once they 
acquire migratory ability, they penetrate through the basal membrane and invade the 
extracellular matrix. (C) Cancer cells enter and circulate blood stream as a form of small 
aggregates. (D) Then, they exit bloodstream and undergo local expansion via 





During metastasis, migration is a crucial process for cells to invade through the 
extracellular matrix (Yamazaki et al., 2005). Alteration of adhesion capacity to 
extracellular matrix enables migration and invasion (Hood et al., 2002). Among several 
factors for migration, changes in integrin expression occur to loosen the adhesion or to 
foster cancer cells’ migration and proliferation during migration (Hood et al., 2002).  
Cell migration process 
 During active migration, cells form actin dependent protrusions to pull themselves 
forward. They first extend filopodia, finger like structures filled with parallel f-actin and 
then merge into lamellipodia, branched networks of actin, when adhering to the ECM 
(Mattila et al., 2008). In order to initiate migration, Rac and Cdc42 activation is by 
phosphatidylinositide 3-kinase (PI3K) is required. PI3K plays a major role in the 
amplification of internal signaling asymmetry and induces cell polarity to promote 
directional cell movements (Yamazaki et al., 2005).  Rac generates protrusive forces by 
local polymerization of actin. Cdc42, which can regulate direction of migration, induces 
actin polymerization to generate filopodia (Raftopoulou et al., 2004). Then, using clusters 
of integrins such as integrins with β1 and integrin αvβ3 (Desgrosellier et al. 2010), cells 
attach onto the extracellular matrix (ECM). Formation of focal adhesion within the 
lamellipodia occurs when cells make contact on ECM (Guo et al., 2004). Rho is 
associated with focal adhesion assembly and contractility. It is also responsible for cell 
body contraction by targeting actin: myosin filament assembly (Raftopoulou et al., 2004).  
Thus, through rho activation, stress fibers composed of actin and myosin at rear sites pull 
the nucleus and cell body forward. Rho is involved in contraction and retraction forces. 
Rac inhibits rho activity at the leading edge of migrating cells. Finally, adhesions at the 
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back end of cells are released by several mechanisms involving simple dissociation of 
integrins or by fracturing the cell-ECM linkage (see Figure 2) (Hood et al., 2002).  
 Cancer cells have different types of migration. When cell-cell junctions are 
present, epithelial cancer cells move as sheet like structures showing collective behavior 
during wound healing or angiogenesis (Yamazaki et al., 2005). When they lose cell to 
cell adhesion by suppressing E-cadherin, a cell-to-cell junction protein, they move as 
single cells. Single cell migrations show two types of morphology. First, mesenchymal 
migration depends on integrin mediated adhesion where cells display an elongated 
morphology. For mesenchymal migration, cancer cells need to degrade ECM. Thus, 
cancer cells often upregulate matrix metalloproteinases (MMPs) and cathepsins, which 
are ECM-degrading enzymes.  MMPs are also accumulated in an integrin dependent 
manner. They remodel surrounding ECMs at the leading edge of migratory cells and help 
elongated cells form a path and overcoming tissue barriers (Friedl et al., 2003; Yamazaki 
et al., 2005).   On the other hand, amoeboid migration where cells maintain a rounded 
morphology is not dependent on integrin function. Since cell-ECM adhesion is weak, 
cancer cells keep their round morphology and squeeze into gaps in the ECM while 
migrating. Cancer cells are able to shift their migration pattern from mesenchymal to 
amoeboid types. Thus, to regulate cancer cell movements, both types of migration need to 





Figure 2: Steps of cell migration. (A) Migrating cells extend lamellipodia and filopodia 
in the direction of migration. (B) Focal adhesion by integrins formed by binding to ECM. 
(C) Stress fiber contracts to pull cell body and nucleus forward. (D) Cells break adhesion 
at trailing edge of cells. (Mattila et al., 2008) 
Integrins in cancer cells 
Cancer cells require integrin mediated adhesion for their directed migration 
(Yamazaki et al., 2005). Integrins are heterodimeric transmembrane receptors for ECM 
molecules expressed on many cell types. There are 24 distinct integrin heterodimers 
expressed in mammals and formed by a combination of 18 α subunits and 8 β subunits 
(see Figure 3). Integrins directly bind components of the ECM and provide the traction 
necessary for cell motility and invasion (Desgrosellier et al. 2010). From direct 
interaction with the ECM, integrins sense the tumor microenvironment and regulate 
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intracellular signaling and cellular responses including proliferation, migration, invasion 
and differentiation. Ligands for integrin include fibronectin, fibrinogen, vitronectin, 
collagen and laminin which are all components of ECM. As integrins form adhesion 
necessary for migration, they cluster into focal contacts containing many different actin-
associated proteins, such as α-actinin, vinculin, tensin and paxillin connecting integrins 







Cancer cells often show drastic alterations in expression levels of integrin and 
integrin affinity for ECM substrates. For example, most adult epithelial cells show very 
low expression levels of integrins αvβ3, α5β1 and αvβ6 whereas tumor cells often 
upregulate expressions of them (Hood et al. 2002). Integrin αvβ3 binds several ECM 
components like fibronectin, fibrinogen, von Willebrand factor, vitronectin and 
proteolysed forms of collagen and laminin and is upregulated in invasive melanoma cells 
and angiogenic blood vessels. Inducing αv or β3 subunit expression showed highly 
increased metastatic potential for melanoma cells in mice or chick embryo model, 
respectively (Felding-Habermann et al., 1992; Hood et al., 2002). Integrin α6β4, a 





Figure 3: Schematic of integrin. Integrin is a transmembrane 
heterodimeric receptor directly binds to ECM. 
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laminin-binding receptor, is not expressed in normal thyroid cells but increased 
expression is positively correlated to invasion of thyroid carcinoma. Some integrins show 
decreased expression level in tumor cells (Hood et al., 2002). Integrin α2β1 had lower 
expression level, possibly inducing dissemination of cancer cells (Kren et al., 2007). Re-
expression of integrin α2β1 in breast cancer cells altered malignant properties of breast 
cancer cells (Desgrosellier et al., 2010).  
Among many integrins, integrin α5β1 is often overexpressed in many cancers 
including colon, ovarian, lung, and breast cancer, as well as in melanomas and gliomas 
(Schaffner et al., 2013). Previous studies have shown an effect of integrin α5β1 
expression level on cancer metastasis. Using a mouse model of ovarian cancer cells 
which metastasize to kidneys, one study showed that cells overexpressing integrin α5 
metastasized more than cells expressing native levels of integrin α5 or cells with 
expressing a defective integrin α5 mutant (Tani et al., 2002). Furthermore, from node-
negative non-small cell lung cancer patients, overexpression of integrin α5 was observed 
in 50% of patients and integrin α5 overexpressing tumors may serve as a marker of 
potential micro metastasis (Masashi et al., 2000). However, the effect of integrin α5β1 on 
cancer is controversial as it has shown both tumor suppressive and protumoral behavior. 
Overexpression of integrin α5β1 has been shown to negatively regulate colon cancer cell 
growth (Schmidt et al., 1998). However, other studies have shown that upregulation of α5 
integrin subunit caused upregulation of cell invasion (Nam et al., 2012). Furthermore, 
suppression of integrin α5β1 by lunasin, a peptide having an RGD motif that integrin 
α5β1 can bind, prevented the outgrowth of colon cancer cells (Dia et al., 2011). This 
study showed the effect of lunasin on colon cancer metastasis by studying human colon 
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cancer cell lines in vitro and a liver metastasis mice model in vivo. The study observed 
that lunasin internalized into nucleus by immunofluorescence microscopy and it 
interacted with integrin α5β1 in human colon cancer cells through co-
immunoprecipitation of lunasin-integrin α5β1. Furthermore, in mice models, lunasin 
treated mice injected with human colon cancer cells exhibited decreased liver metastasis. 
Similar to colon cancer, initial study on integrin α5β1 in breast cancer showed a tumor 
suppressive effect (Seftor et al., 1998).  This study tested the effect of Maspin, a serine 
protease inhibitor/non-inhibitor superfamily, on a highly invasive breast cancer cell line, 
MDA-MB-435. Maspin suppressed the invasive phenotype of MDA-MB-435 in invasion 
assays performed with MICS chamber pore coated with fibronectin. Treatment of Maspin 
also exhibited increased expression of integrin α5, αv and β1 at both mRNA and protein 
level indicating effect of increased expression of integrin on cell invasion (Seftor et al., 
1998). However, later studies challenged this result. Invasive breast cancer cell, MDA-
MB-231, with a higher expression level of integrin α5β1 showed increased invasion into 
3D collagen matrix through enhanced contractile force (Mierke et al., 2011). Integrin α5 
was proposed to be positively involved in lung metastasis of human breast cancer cells, 
MDA-MB-231, in mice model by studying effect of nischarin, integrin α5 binding 
protein (Baranwal et al., 2011). When nischarin- or control vector- expressing MDA-MB-
231 cells were injected into mice, control cells showed increased lung metastasis with 
increased tumor growth and higher integrin α5 expression levels. However, the role of 





Two dimensional and three dimensional models for in vitro testing 
The extracellular matrix (ECM) is a complex array of secreted molecules such as 
collagen, fibronectin, elastin, fibrinogen, vitronectin and laminin assembled into diverse 
structures to constitute the cell microenvironment (Kim et al., 2011). Previously to 
investigate cell signaling, migration, adhesion, and even cytoskeletal function, many 
studies were performed on planar 2D ECM substrates. Conventional 2D model consisted 
of seeding cells on top of a culture plate coated with ECM components. This poorly 
mimics the extracellular conditions of  living organisms (Hess et al., 2010), whereas3D 
cell culture models provide a microenvironment  which simulates in vivo conditions and 
promotes morphology, motility, signaling and polarity that more closely resembles cells 
in vivo (See Figure 4). 
To develop a 3D gel, type I collagen is often used. Among many components in 
ECM, collagen is the most abundant protein that constitutes up to 30% of the total protein 
mass. It is a main structural element of ECM providing tensile strength, regulating cell 
adhesion, support chemotaxis and migration and tissue development (Frantz et al., 2010). 
Moreover, type I collagen is easily accessible and able to polymerize. Additionally, to 
study the effect of integrin on cell migration or invasion, fibronectin or vitronectin is 
added depending on specific ligand of integrin prior to collagen polymerization (Mierke 
et al., 2011).  For migration or invasion, vertical gel 3D assay can be used by seeding 
cancer cells on top of collagen gels. The vertical 3D assay is used to monitor 3D cell 
migration by counting the cell numbers. However, 3D vertical assay cannot measure how 
cells move into the gel and how fast cells move. It is hard to set the border line of 















 We utilized both 2D and 3D models to study the effect of integrin α5 on cell 
motility.  However, as we do not fully understand how cells move in ECM while 
migrating to secondary tumor sites, cell movements in ECM and effects of integrin α5 on 
cell motility need to be investigated more. We investigated cell movements using a 
traditional 2D cell migration model by coating plates with different ECM components. 
As vertical 3D model only provide how many cells migrate into 3D matrix, we monitored 
cell movements by embedding cells in 3D gel to provide in vivo like environment. From 
2D and 3D model, we confirmed that 3D model provide better characterization of cell 
motility than 2D and ECM structure also affects cell motility. By using metastatic breast 
cancer cell, MDA-MB-231, we confirmed that higher expression level of integrin α5 also 
induces migration of cancer cells in 3D collagen matrices.  
 
Figure 4: Cell morphology in 2D and 3D matrices. (A) Cell in 2D culture is very 
flat. (B) Cell in 3D culture is more round mimicking in vivo tumor 
microenvironment. (Giri et al. Not published) 
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Anisotropic persistent random walk (APRW) model 
 Cell motility on 2D has been described by a persistent random walk (PRW) model 
which indicates that cell movements are highly isotropic in the absence of gradients and 
assumes a Gaussian distribution of cell velocities. Speed and persistence of cell 
movements can be obtained from fitting mean squared displacements (MSD) of cell 
movements with a PRW model (Stokes et al., 1991). However, since mechanisms of 2D 
and 3D cell migration are different, 3D cell movement does not follow PRW model but 
rather displays a highly anisotropic pattern (Wu et al., 2015). As described earlier, cells in 
3D can alternate its movement between mesenchymal and amoeboid migration. Unlike 
cell migration in 2D, they do not display lamellipodia or filopodia when embedded in a 
3D matrix. Human fibrosarcoma (HT1080) cells embedded in a 3D collagen matrix, 
display an exponential-like distribution not the predicted Gaussian distribution. 
Considering angular displacement and velocity profiles over different orientations, cell 
movements in 3D are highly anisotropic and more closely follow the APRW model. 
When movements of several cell lines in both 2D and 3D matrices were fitted with PRW 
and APRW models, APRW model did describe 3D migration well with a higher 
goodness of fit (see Table 1) (Wu et al., 2015). By fitting cell trajectories obtained with 
the APRW model, speed and persistence along the primary and non-primary axis of cell 
movements can be obtained. From speed and persistence along the primary and non-
primary axis, we can calculate diffusivity (D = S
2
P/4) to describe how fast cells diffuse 
into a matrix. After calculating primary and non-primary diffusivities, a strong 
correlation between diffusivity and persistence was observed from cell migration in 3D 





Human breast carcinoma cells MDA-MB-231 were cultured in Dulbecco’s 
modified Eagle’s medium, high glucose (4.5g/L) (DMEM, Mediatech), supplemented 
with 10% fetal bovine serum (Hyclone Laboratoreis) and 1% Pen/Strep (Sigma). Cells 
were maintained in an incubator with 5% CO2 at 37°C. MDA-MB-231 cells with non-
target control (NTC) and integrin α5 knock down (shITGA5 KD) by shRNA were 
established with viral transduction of shITGA5 expressing lentriviral constructs (Sigma 
Aldrich). Cells were culture in Dulbecco’s modified Eagle’s medium, high glucose 
(4.5g/L) (Mediatech), supplemented with 10% fetal bovine serum (Hyclone), 1% 
Pen/Strep (Sigma) and 1μg/ml puromycin.  
 
Cell Proliferation PrestoBlue Assay 
 To generate the standard curve of proliferation rate of MDA-MB231-cells, 
different numbers of cells (500, 1,000, 5,000, 10,000, 50,000, 100,000, 200000, and 
250,000) were seeded in 24 well plates and cultured overnight. Each well was then 
incubated with 100μl PrestoBlue reagent (Invitrogen) for 1 hr or 2 hr with 5% CO2 at 
37°C. 200μl of cell culture media with PrestoBlue reagent were collected in 96 well 
plates. The absorbance was measured using a plate reader with excitation and emission 
wavelength at 560nm and 590 nm. 
3000 cells were seeded in 24 well plates and cultured for 8 days. Cells were 
incubated with 100μl PrestoBlue reagent for 1 hr with 5% CO2 at 37°C and 200μl cell 
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culture media and PrestoBlue reagent mixtures from each day were collected in 96 well 
plates. Fluorescence was measured.  
 
2D cell migration assay 
Two-dimensional cell-culture 24 well plates were coated with different matrices 
before seeding cells. Soluble rat tail type I collagen (Corning Inc.) in acetic acid were 
coated to achieve a final concentration of 50μg/ml and plates were washed gently three 
times with PBS. 50μg/ml fibrinogen in PBS and 50μg/ml fibronectin (Fisher Scientific) 
in sterile water were also coated and washed with PBS or sterile water, respectively. 
Plates were incubated for 1 h at room temperature and seeded with cells. 
For 2D, cells were incubated for 1 h before time-lapse movies were acquired. Cell 
movements over time were imaged using a Cascade 1K CCD camera (Roper Scientific) 
mounted on mounted on a Nikon TE2000E phase contrast microscope equipped with a 
10X objective and controlled by NIS-Elements AR imaging software. Images were taken 
every 5 minutes for 13 hours. Cells in the time-lapse movies were tracked using 
MetaMorph imaging software. The results were exported to an excel file which contained 
the x-, y- coordinates, time interval and speed of the tracked cells. 
 
3D cell migration assay 
3D collagen matrices were prepared with soluble rat tail type I collagen in acetic 
acid (Corning) to achieve a final concentration of 1mg/ml collagen. 1 M NaOH was then 
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added to normalize pH to about 7.0. For 3D collagen-fibronectin matrices, 10 and 
50μg/ml fibronectin in sterile water for final concentration of 10 and 50μg/ml was added 
to collagen 3D matrices immediately after normalizing matrices with 1M NaOH. 
Remaining volume filled with a 1:1 ratio of reconstitution buffer [0.2 Hepes (Sigma-
Aldrich), 0.26 M NaHCO3 (Sigma-Aldrich), and water as solvent] and culture medium. 
For 3D fibrinogen matrices, 100μl of 5mg/ml or 10mg/ml fibrinogen stock was mixed 
with 10μl of 100u/ml thrombin stock and 5μl 100mM CaCl2 stock to achieve final 
concentration of 0.16mg/ml or 0.32mg/ml. To achieve total volume of 315μl, remaining 
volume filled with PBS. All matrices were placed in 24-well culture plates. All of gels 
solidified within 1h in an incubator at 5% CO2 and 37°C, then 500μl of cell culture 
medium were added. 
For 3D experiments, cells were incubated for 1h or overnight before time-lapse 
movies were acquired. Cell movements over time were imaged using a Cascade 1K CCD 
camera (Roper Scientific) mounted on a Nikon TE2000E phase contrast microscope 
equipped with a 10X objective (Nikon) and controlled by NIS-Elements AR imaging 
software (Nikon). Images were taken every 5 minutes for 13 hours for 3D experiments. 
Cells in the time-lapse movies were tracked using MetaMorph imaging software. The 
results were exported to an excel file which contained the x-, y- coordinates, time interval 






2D and 3D APRW Model Analysis 
APRW model analysis was performed as described previously (Wu et al., 2015). 
Briefly, x- and y-coordinates from 2D and 3D cell trajectories data were exported from 
cell tracking Metamorph (Molecular Devices) software. Then, statistical profiling of cell 
motility was performed with Matlab. Statistical profiling includes MSD, correlation of 
cell velocities at different time lag, occurrence or probability distribution of cell 
displacement, occurrence of cell angular displacements and average magnitude of cell 
speed evaluated at different orientations after re-alignment along the primary migration 
direction. Cell trajectories data were then fitted to the APRW models. APRW model 
fitting generates speed of cells, diffusivity, persistent time and anisotropic index. 
Statistical profiling of fitting results was also performed with Matlab. Simulated cell 
trajectories based on APRW model fitting were then used to obtain MSDs.  
Statistical Analysis 
The mean values ± standard errors (SE) were calculated and plotted using Graphpad 
Prism software (GraphPad Software). One-way and two-way ANOVA test was 
performed to determine statistical significance, which is indicated in the graphs using the 
standard Michelin grade scale ***p<0.001, **p<0.01 and *p<0.05.  
Reflection Microscopy 
Reflection microscopy was performed for 3D matrices. Cells were plated in 3D matrices 
with collagen only and collagen with fibronectin. After waiting for overnight, gel 
structures were imaged using a Nikon A1 confocal microscope using 60X oil-immersion 




Immunofluorescence in 2D was performed. Cells were plated on the fibronectin, 
fibrinogen and collagen gels. After overnight incubation, cells were fixed with 4% 
formaldehyde for 10 min and permeabilized with  0.1% Triton-X 100 (v/v) for 10 min. 
Cells were then incubated with vinculin antibody (Sigma-Aldrich) at 1:150 dilution  and 
integrin α5 antibody (Abcam) at 1:250  for 1 hr at room temperature. Following washes 
in PBS cells were incubated with phalloidin (Invitrogen) at 1:150 dilution ratio and anti-
mouse and rabbit antibodies at 1:200 dilution ratio for both for 1 hr at room temperature. 
Then, cells were incubated with hoechst 33342 at 1:200 dilution ratio. Cells at 2D were 

















The role of integrin α5 in cancer is controversial. Some literature suggests a tumor 
suppressive effects of integrin α5β1 (Seftor et al., 1998) while other study shows a 
positive correlation with cancer metastasis and tumorigenesis (Baranwal et al., 2011). 
Some studies report that tumor cells have appropriate integrin α5β1 expression level for 
metastasis (Tani et al., 2002). Too high or too low expression level had negative effect on 
the metastasis by observing kidney metastasis of ovarian cancer cells in mice injected 
with ovarian cancer cells expressing different levels of integrin α5 (Tani et al., 2002). In 
our work, we have tested the effect of integrin α5 on cancer cell migration on different 
types of matrices as integrin is a receptor for cell-ECM interactions.  
Downregulation of α5 integrin decreases cell growth in 2D cultures 
To test the effect of downregulation of α5 integrins on breast cancer cell 
proliferation, we compared the growth of MDA-MB-231 metastatic breast cancer cells 
expressing a shRNA targeting integrin α5 (shITGA5) or a non-target control (NTC) on 
different 2D matrices including fibronectin, fibrinogen and collagen. We observed NTC 
cells grew faster than shITGA5 cells (See Figure 5 A, B). For shITGA5 cells, 
proliferation curves were quite similar on all types of coatings. In vitro proliferation was 
decreased when expression of integrin α5 was lowered. We confirmed reduced expression 




Figure 5: Proliferation rate of NTC and shITGA5 cells. (A) NTC cells on collagen 
showed slower cell growth rate compared to other coatings. (B) Cell growth rates of 
shITGA5 cells on all 2D coatings are reduced compared to NTC cells. Y axis presents 
relative fluorescence unit representing cell numbers.  
 
 
Figure 6: RT-PCR and western blots to detect mRNA and protein levels of integrin α5. 
(A) RT-PCR results showed around 8 fold decrease in ITGA5 mRNA levels between 
NTC cells and integrin α5 knockdown cells in integrin α5 (ITGA5) expression level. (B) 
The protein levels of integrin α5 were reduced in knockdown cells. 
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Downregulation of integrin α5 did not have drastic effects on 2D cell motility 
To test cancer cell motility on different matrices, we plated breast cancer cells 
MDA-MB-231, on fibronectin, fibrinogen and collagen coated plates. Cell motilities 
were monitored every 5min for 13h using live-cell phase-contrast microscopy. Compared 
to cells plated without coating, we observed cells are remarkably both NTC and shITGA5 
cells were more motile on collagen coated matrices (See Figure 7 A). We also expected 
cells migration speed on collagen would not be affected. While the migration of shITGA5 
cells on collagen coated matrices are decreased compared to controls, cell speeds on 






















Figure 7: The effects of integrin α5 downregulation on 2D coatings. (A) Average cell 
velocity by cell type. Cells on collagen coating showed significantly increased average 
cell velocities for NTC, shITGA5-1 and shITGA5-5 cells. Average cell velocities on no 
coating, fibronectin and fibrinogen were not affected by expression of integrin α5. (B) 
Average velocities compared by coatings. Only average velocity on collagen for 
shITGA5-5 cells reduced.  
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To ensure that fibronectin concentration does not affect cell speed, we also plated 
NTC and shITGA5 cells on different fibronectin concentration coatings. In a previous 
study, the speed of cell migration depends on the substrate extracellular matrix 
concentration (Palecek et al. 1997). We did not observe remarkable differences of cell 
migration speeds on different concentrations of fibronectin coating. The correlation 
between cell speeds and fibronectin concentrations was similar on both NTC and 









For MDA-MB-231 cells on 2D coated substrates, APRW model provides a better 
fit for motility data compared to the PRW model (Wu et al. 2015). Furthermore, from 
NTC cells on no coating, orientation of the velocities of cell migration relative to the 
primary axis indicated that even movements of NTC cells without any coating are 
intrinsically anisotropic (see Figure 9). 
Figure 8: Average velocity on different fibronectin concentrations. No 
significant change of average velocity on different fibronectin concentration 













We performed the APRW model fitting for NTC and shITGA5 cells on no 
coating, fibronectin, fibrinogen and collagen. As MSD graphs indicate, the APRW model 
fitted 2D cell motilities with R-squared value higher than 0.95 for all cell types and 
coatings (see Figure 10). From MSD values for cells plated on no coating, fibrinogen and 
collagen, NTC cells moved slightly faster than shITGA5 cells. Consistent will cell 
motilities calculated from average velocity measurements (see Figure 7 B), cell 
movements on fibronectin coatings indicated no difference between NTC and shITGA5 
cells. 
Figure 9: Orientation of the velocities of cell migration relative to the primary 
axis. NTC cell motility on no coating (in green dots) showed that it followed 
APRW model (in red line) rather than PRW model (in blue line). NTC cell 
movements on 2D were highly anisotropic, not following PRW model. 
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Figure 10: Mean squared displacement from cell trajectories and APRW fitting. (A) 
MSD from no coat (B) from fibronectin coating (C) from fibrinogen coating and (D) 
collagen coatings with R-squared values higher than 0.95.  
 
Since 2D cell motilities follow an APRW model, we can obtain different cell 
motility parameters such as total diffusivity and persistent time. Total diffusivities and 
primary persistence times of NTC cells on no coating, fibrinogen and collagen were 
greater than those of shITGA5 cells. On the other hand, 2D cell movements on 
fibronectin were not affected by expression of integrin α5. Moreover, primary persistent 
times on fibronectin coating were not affected (see Figure 11). Integrin α5 expression 























To evaluate the correlation between focal adhesion formation and cell motility, 
we plated NTC and shITGA5 cells on the glass bottom plate coated with different 
matrices. Then, we fixed cells with 4% formaldehyde for 10 min at room temperature. 
We stained cells with integrin α5, vinculin and actin. By visual inspection, we observed 
more focal adhesions for NTC cells than for shITGA5 cells (see Table 1). For NTC cells, 
focal adhesion staining overlapped with staining for integrin α5. This was observed from 
cells plated on fibronectin, fibrinogen, no coating (see Figure 12). For shITGA5 cells, 
focal adhesions still formed on all of 2D coatings with downregulation of integrin α5. For 
A   B 
Figure 11: Total Diffusivity and primary persistent time on 2D coatings. (A) Total 
diffusivity, sum of primary diffusivity and non-primary diffusivity, showed that NTC 
cells on no coating (NO), fibrinogen (FIB) and collagen (COL) are moved faster than 
shITGA5 cells. However, cell movements on fibronectin (FN) were not influenced by 
integrin α5 expression level. (B) Primary persistent time on 2D coatings showed 




both NTC and shITGA5 cells, less focal adhesions were formed on collagen. Integrin 




Number of + indicates intensity of focal adhesions 
 











Figure 12: Focal adhesion of cells on 2D coating from immunostaining. (A) NTC 
cells on no coating showed vinculin (a marker of focal adhesions) (in red) and 
integrin α5 (in green). (B) shITGA5 cells on no coating still displayed vinculin 
staining focal adhesion. (C) NTC cells on fibronectin coating showed vinculin 
staining overlaps with integrin α5. (D) shITGA5 cells on fibronectin still formed 
vinculin focal adhesions. Nucleus (in blue), and actin (in pink).  
 
Table 1: Focal adhesion numbers per cell on 2D coatings 
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To observe 3D matrices structures, we performed reflection microscopy for gels 
with collagen only, collagen with 10μg/ml fibronectin and collagen with 50μg/ml 
fibronectin. With increasing amounts of fibronectin in collagen matrices, a tighter gel 
structure was observed (see Figure 13 A, B, C). Pore sizes for each matrices indicated 
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Figure 13: Gel structures from reflection microscopy. (A) Collagen 1mg/ml, (B) 
Collagen 1mg/ml with fibronectin 10μg/ml showed similar gel structure with collagen 
only 3D matrix, (C) Collagen 1mg/ml with fibronectin 50μg/ml. We observed tighter 
fiber formation for increasing amount fibronectin in collagen matrices. (D) Pore size of 
3D matrices. Collagen with fibronectin (FN) 50μg/ml had smaller pore size than 




Downregulation of integrin α5 remarkably decreased cell motility in 3D 
To test the effect of downregulation of integrin α5 on cell motility in 3D matrices, 
we cultured NTC and shITGA5 cells embedded in collagen alone and collagen-
fibronectin matrices. We monitored cell migration for 13 h using live cell phase contrast 
microscopy. Unlike 2D cell culture, cell migration speeds of NTC and shITGA5 cells had 
no difference in 3D collagen. Even with fibronectin added in matrices, cell speeds were 
not affected (see Figure 14).  
 
Figure 14: Average velocity in 3D matrices. (A) Average velocity of cells in collagen, (B) 
Average velocity of cells in collagen with fibronectin 10μg/ml, (C) Average velocity of 
cells in collagen with fibronectin 50μg/ml. Average velocities were not affected by 
















Thus, we performed APRW model fitting for cell migration trajectory data for 
more accurate statistical analysis. Cell movements in 3D matrices were fitted with 
APRW model with R-squared values around 0.99 showing high goodness of fit (see 
Figure 15).  
 
Figure 15: Mean squared displacement from cell trajectories and APRW model. (A) 
MSD from cell trajectories. (B) MSD from APRW model with R-squared values around 
0.99 showing 3D cell motilities follow APRW model. 
For more accurate characterization of cell motilities in 3D matrices, we measured 
primary persistent time, total diffusivities and anisotropic indexes. Primary persistent 
times for shITGA5 cells remarkably decreased compared to NTC cells. In addition to 
persistent time, total diffusivities that can be calculated from cell speed and persistent 
time also drastically decreased for shITGA5 cells unlike average velocities (see Figure 16 
A, B). Both diffusivities for primary and non-primary axis remarkably decreased (see 
TABLE 2). NTC cells moved dramatically faster in 3D matrices showing effect of 
integrin α5 expression level. Furthermore, increasing amounts of fibronectin in gels 






























































NTC Collagen & FN 10ug/ml
NTC Collagen & FN 50ug/ml
shITGA5 Collagen 1mg/ml
shITGA5 Collagen & FN 10ug/ml
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shITGA5 Collagen & FN 10ug/ml








due to changes of gel structures. According to anisotropic index, in 3D collagen matrices 
with fibronectin, shITGA5 cells showed more isotropic cell movements (see Figure 16 C). 
Moreover, shITGA5-2 cells have higher expression of integrin compared to shITGA5-1 
(see Figure 6 B). shITGA5-2 cells showed higher persistent time total diffusivity 
confirming that integrin α5 expression affect cell motility. Average velocities obtained 
from cell trajectories were not affected but total diffusivities and persistent time altered 
due to downregulation of integrin α5. As total diffusivity is calculated from cell speed 
and persistent time, correlation between total diffusivity and persistent time shows that 
persistent time is major factor that affects cell motility (see Figure 16 D).  
Cell motility increased with decreasing expression level of integrin α5 for 3D 
fibrinogen 
To investigate the effect of integrin α5 on cell motility in 3D fibrinogen, we 
plated cells in 3D fibrinogen matrices. From both average velocities and total diffusivity 
obtained from APRW model, cells with lower expression of integrin α5 moved faster 
regardless of concentration of fibrinogen (see Figure 17). For NTC cells, cell motility 
decreased with increasing amount of fibrinogen potentially due to stiffness of gel matrix. 
However, shITGA5 cells were not affected by the concentration of fibrinogen. While 
total diffusivities for shITGA5 cells in fibrinogen remained similar to diffusivities of cells 
in a collagen only matrix, total diffusivity for NTC cells in fibrinogen was decreased by 
























Figure 16: Cell motility parameters from APRW model fitting. (A) Primary persistent time. 
Primary persistence decreased with downregulation of integrin α5. (B) Total diffusivity. With 
increasing amounts of fibronectin in 3D matrices, cell movements decreased potentially due to 
change of gel structure. (C) Anisotropic index. Anisotropic index showed that in 3D matrices 
with fibronectin, shITGA5 cells moved more in isotropic manner. (D) Correlation between 
primary persistence and total diffusivity. Positive correlation between total diffusivity and 
















Figure 17: Average velocity and total diffusivity for 3D fibrinogen. shITGA5 cell 





Pp: primary persistent time (min), Pnp: non-primary persistent time 
(min), Dp: primary diffusivity (μm
2
/min), Dnp: non-primary 
diffusivity (μm
2
/min), Dtotal: toal diffusivity = Dp + Dnp (μm
2
/min) 
and φ: anisotropic index = Dp/Dnp 





 As integrin plays important role in cancer migration, proliferation invasion 
and angiogenesis, many studies on integrin as therapeutic target were performed 
(Schaffner et al., 2013). Our work agrees with several studies suggesting integrin α5 
plays major role in breast cancer metastasis involving migration, invasion and 
proliferation. Integrins regulate not only cell migration and invasion but also proliferation 
and/or survival of cancer cells. Previous studies have shown that integrin α5β1binding to 
fibronectin inhibits drug induced apoptosis and upregulation of integrin α5β1 promotes 
tumor cell survival (Aoudjit et al., 2001). Our work is consistent with these findings. 
Integrin α5 knock down led to a decrease in cell growth, indicating integrin α5β1 plays an 
important role for cancer cell growth. As overexpression of nischarin, integrin α5 binding 
protein, also decreased tumor growth (Baranwal et al., 2011), suggesting that targeting 
integrin α5 as potential therapeutic solution would inhibit breast cancer growth.  
Studies have shown that on fibronectin coated plates, breast cancer cells 
transfected with siRNA targeting integrin α5 showed less migration area exhibiting 
decreased cell motility and suggesting elevated integrin α5 resulted from steroid receptor 
coactivator-1 in tumors is important for breast cancer cell migration (Qin et al., 2011). 
However, other studies have shown that when endothelial cells were cultured on 
fibronectin coated with antibody blocking integrin α5, percentage of motile cells were 
decreased but cell speeds were not affected (Chon et al., 1998). The discordance among 
studies may be a result of the different cell types that were studied. As fibronectin is main 
ligand for integrin α5β1, we expected downregulation of integrin α5β1 would affect 
cancer cell motility on fibronectin coating. However, as our work exhibited, effect of 
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integrin α5β1 in cancer cell motility on collagen was greater than any other type of 
coating. Secretion of fibronectin by cells and binding of fibronectin onto collagen may 
affect cancer cell motility on collagen coating as well. As integrin α5β1 is mainly known 
for fibronectin receptor, we evaluated the effect of fibronectin concentration on cell 
motility.  Consistent to previous study (Chon et al., 1998), we did not observe significant 
differences between cell speeds on various concentrations.   
Our work exhibited that expression level of integrin α5 as well as ECM 
component affects 3D cancer cell motility in collagen including total diffusivity and 
primary persistence from APRW model. We further need to investigate how ECM 
components affect cell motility in different 3D matrices. Other studies have shown that 
metastatic breast cancer cells with higher expression of integrin α5β1 invaded more into 
3D collagen gel (Mierke et al., 2011). Decrease of cell motility in 3D model suggests 
integrin α5 as potential therapeutic target for inhibiting cancer cell migration and 
invasion. Baranwal et al. identified nischarin, a protein binding to proximal 
transmembrane region of integrin α5 cytoplasmic tail and observed that nischarin reduced 
proliferation and lung metastasis. However, the mechanism of how nischarin regulates 
cancer migration and invasion is not known. In preclinical studies, integrin α5β1 
function-blocking murine antibody, IIA1, was able to promote apoptosis of breast cancer 
cells in 3D culture (Nam et al., 2010). ATN-161 developed by Attenuon LLC is actylated 
amidated PHSCN peptide and it blocks cancer growth and metastasis in preclinical 
mouse models. ATN-161 with radiotherapy also induced apoptosis of breast cancer 
growth in 3D culture (Schaffner et al., 2013).  PHSCN dendrimers were able to inhibit 
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human prostate cancer invasion, lung metastasis, breast cancer invasion in vivo. 


















Our work here focuses on the effect of integrin α5 on cell motility for 2D coatings 
and 3D matrices. To test the effect of integrin α5 on 2D cell migration, cell movements 
on fibronectin, fibrinogen and collagen were observed. According to average velocity 
analysis, which measures cell velocity from cell trajectories, we observed cell motility 
was not affected. However, we were able to observe cell movements on no coating, 
fibrinogen and collagen were affected by expression of integrin α5 through APRW model. 
Total diffusivities and persistence times for cells with downregulation of integrin α5 were 
decreased for no coating, fibrinogen and collagen. Cell migration on fibronectin was not 
affected by integrin α5 expression levels. We studied the effect of focal adhesion on 2D 
cell migration. However, we were not able to establish any correlation between the 
expression level of integrin α5 and cell motility.  
To further study effect of cell motility, we studied cell migration in 3D matrices. 
As 3D cell culture simulates in vivo tumor microenvironment, we were able to perform 
better characterization on effect of integrin α5 on 3D cell migration. Initially, from 
average velocity, we did not observe any effect of integrin α5. We also did not observe 
any effect of fibronectin in 3D collagen matrices. However, interestingly, by APRW 
model fitting, we confirmed that decreased expression level of integrin α5 drastically 
reduced cell migration in 3D. We observed remarkable decreases on total diffusivity and 
persistent time showing strong correlation between two cell motility parameters. We also 
studied the effect of fibronectin in 3D collagen matrices and confirmed that with an 
increasing amount of fibronectin in 3D collagen, the gel structure was altered and tighter 
fiber formation occurred. Potentially due to structure changes in the gel, we observed 3D 
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cell motility decreased with more amounts of fibronectin in matrices.  We also 
investigated cell motility in 3D fibrinogen matrix. We observed a negative correlation 
between integrin α5 expression level and cell migration was observed. With decreasing 
expression of integrin α5, cells moved faster and diffused faster in the 3D fibrinogen 
matrices. Furthermore, fibrinogen concentration did not affect shITGA5 cells but did 
decrease cell motility for NTC cells.  
Our work confirmed that APRW model provided better characterization of cell 
migration and persistence as compared to measuring the average speed from cell 
trajectories. Furthermore, downregulation of integrin α5 had a more drastic effect on 3D 
cell migration than 2D cell motility. Integrin α5 showed opposite effects on 3D cell 
migration in collagen matrices with fibronectin and fibrinogen matrices. 2D cell motility 
had different movement patterns compared to 3D cell motility. Moreover, for 3D, 










For future work, we will quantify focal adhesion and test correlation between cell 
motility and focal adhesion to confirm our results that focal adhesion was not a predictor 
for 2D cell migration. Moreover, to ensure that other types of integrin α were not affected 
by knocking down integrin α5, we will perform flow cytometry, RT-PCR or 
immunoblotting for other integrin α subunits.  
We propose to further investigate correlation between focal adhesion and cell 
motility in 3D matrices. As we observed remarkable difference in 3D migration, focal 
adhesion, involved in cell migration, in 3D gels might be affected as well. Moreover for 
3D cell motility, we plan to manipulate gel composition by altering collagen and 
fibronectin concentrations. As different cell invasion rates into 3D matrices with various 
concentrations of collagen matrices were observed, we propose to further investigate 
relationship between gel structures and 3D cell migration. To further study cell motility 
in 3D fibrinogen matrix, we plan to examine effects of fibrinogen gel structure, stiffness 
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